Solara Active Pharma Sciences Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Solara Active Pharma Sciences Share Price

580.707.91 (1.38%)

Closed
As On: 11 Jun, 2026, 03:59 PM IST
As On: 11 Jun, 2026, 03:45 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	565.50
High	616.00
Low	565.50
Prev Close	572.80
Volume	9,82,658
VWAP(₹)	598.67

Key Metrics

PE Ratio(x)	-377.52
EPS - TTM(₹)	-1.54
MCap(₹ Cr.)	2,782.28
MCap Rank	73
PB Ratio(x)	2.20
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	734.40
52W Low(₹)	422.00
MCap/Sales	1.38
Beta(1 Month)	1.98
BV/Share(₹)	260.63

Solara Active Pharma share price insights

Employee & Interest Expense
Company has spent 6.92% of its operating revenues towards interest expenses and 16.01% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Solara Active Pharma Share Price Update
Solara Active Pharma Sciences Ltd. share price moved up by 1.38% from its previous close of Rs 572.80. Solara Active Pharma Sciences Ltd. stock last traded price is 580.70
Share Price Value
Today/Current/Last 580.70578.50
Previous Day 572.80572.55

Found Insights useful?

Solara Active Pharma Share Price Returns

1 Day	1.38%
1 Month	10.28%
3 Months	28.46%
1 Year	13.2%
3 Years	63.1%
5 Years	-66.15%

Solara Active Pharma Share Recommendations

Recent Recos

Target₹400
OrganizationMotilal Oswal Financial Services
BUY

Target₹520
OrganizationICICI Securities
BUY

Target₹488
OrganizationICICI Securities
BUY

View all Stock Recommendations

News & Analysis

View all Solara Active Pharma Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	391.98	349.00	314.03	320.13	278.96
Total Income Growth (%)	12.32	11.14	-1.91	14.76	-7.57
Total Expenses	354.81	343.98	303.30	285.71	251.94
Total Expenses Growth (%)	3.15	13.41	6.16	13.40	-5.70
EBIT	37.17	5.02	10.73	34.42	27.02
EBIT Growth (%)	640.44	-53.22	-68.83	27.39	-21.98
Profit after Tax (PAT)	9.60	-17.43	-10.10	10.52	-2.10
PAT Growth (%)	-	-	-196.01	-	-125.96
EBIT Margin (%)	9.48	1.44	3.42	10.75	9.69
Net Profit Margin (%)	2.45	-4.99	-3.22	3.29	-0.75
Basic EPS (₹)	2.20	-3.98	-2.36	2.46	-0.93

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	391.71	349.00	314.03	320.13	278.96
Total Income Growth (%)	12.24	11.14	-1.91	14.76	-7.57
Total Expenses	354.92	343.97	303.28	285.70	254.72
Total Expenses Growth (%)	3.18	13.42	6.15	12.16	-4.66
EBIT	36.79	5.03	10.75	34.43	24.24
EBIT Growth (%)	631.41	-53.21	-68.78	42.04	-30.02
Profit after Tax (PAT)	9.73	-17.42	-10.08	10.53	-4.88
PAT Growth (%)	-	-	-195.73	-	-160.25
EBIT Margin (%)	9.39	1.44	3.42	10.76	8.69
Net Profit Margin (%)	2.48	-4.99	-3.21	3.29	-1.75
Basic EPS (₹)	2.23	-3.97	-2.36	2.46	-1.65

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	1,375.14	1,292.08	1,294.29	1,466.36	1,288.36
Total Revenue Growth (%)	6.43	-0.17	-11.73	13.82	-21.71
Total Expenses	1,376.66	1,291.54	1,592.54	1,511.18	1,375.97
Total Expenses Growth (%)	6.59	-18.90	5.38	9.83	-3.38
Profit after Tax (PAT)	-7.41	0.54	-567.39	-22.18	-58.15
PAT Growth (%)	-1,472.22	-	-	-	-126.26
Operating Profit Margin (%)	6.81	8.98	-14.98	3.13	-0.97
Net Profit Margin (%)	-0.54	0.04	-44.02	-1.53	-4.58
Basic EPS (₹)	-1.68	0.14	-157.62	-6.16	-16.18

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	1,374.87	1,292.90	1,294.29	1,465.95	1,287.10
Total Revenue Growth (%)	6.34	-0.11	-11.71	13.90	-21.77
Total Expenses	1,376.22	1,293.98	1,592.98	1,510.73	1,375.27
Total Expenses Growth (%)	6.36	-18.77	5.44	9.85	-3.44
Profit after Tax (PAT)	-7.24	-1.08	-566.87	-22.21	-58.56
PAT Growth (%)	-	-	-	-	-126.50
Operating Profit Margin (%)	6.78	8.85	-14.95	3.13	-1.01
Net Profit Margin (%)	-0.52	-0.08	-43.98	-1.53	-4.61
Basic EPS (₹)	-1.64	-0.27	-157.48	-6.17	-16.29

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent 6.92% of its operating revenues towards interest expenses and 16.01% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	2,332.59	2,231.84	2,350.96	2,899.28	2,952.53
Total Assets Growth (%)	4.51	-5.07	-18.91	-1.80	12.97
Total Liabilities	1,077.04	1,134.93	1,414.38	1,396.83	1,425.35
Total Liabilities Growth (%)	-5.10	-19.76	1.26	-2.00	39.63
Total Equity	1,255.55	1,096.91	936.58	1,502.45	1,527.18
Total Equity Growth (%)	14.46	17.12	-37.66	-1.62	-4.12
Current Ratio (x)	0.96	0.77	0.64	1.08	1.16
Total Debt to Equity (x)	0.53	0.71	1.07	0.67	0.67
Contingent Liabilities	0.00	57.61	42.63	38.00	66.88

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	2,276.59	2,225.10	2,346.60	2,894.95	2,949.67
Total Assets Growth (%)	2.31	-5.18	-18.94	-1.86	13.01
Total Liabilities	1,021.15	1,128.89	1,409.18	1,391.82	1,422.62
Total Liabilities Growth (%)	-9.54	-19.89	1.25	-2.17	39.83
Total Equity	1,255.44	1,096.21	937.42	1,503.13	1,527.05
Total Equity Growth (%)	14.53	16.94	-37.64	-1.57	-4.13
Current Ratio (x)	0.91	0.78	0.64	1.09	1.16
Total Debt to Equity (x)	0.49	0.71	1.07	0.67	0.67
Contingent Liabilities	0.00	57.61	42.63	38.00	66.88

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	152.91	212.82	108.87	156.25	-242.03
Net Cash used in Investing Activities	-98.83	-36.83	-3.51	-81.14	-242.85
Net Cash flow from Financing Activities	-53.55	-180.48	-105.65	-112.76	333.57
Net Cash Flow	0.53	-4.49	-0.29	-37.65	-151.31
Closing Cash & Cash Equivalent	4.48	3.95	8.44	8.73	46.38
Closing Cash & Cash Equivalent Growth (%)	13.42	-53.20	-3.32	-81.18	-76.54
Total Debt/ CFO (x)	4.35	3.65	9.18	6.41	-4.23

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	152.89	212.80	110.95	156.17	-241.77
Net Cash used in Investing Activities	-50.14	-36.83	-4.66	-81.13	-243.08
Net Cash flow from Financing Activities	-102.56	-180.48	-106.52	-112.76	333.59
Net Cash Flow	0.19	-4.51	-0.23	-37.72	-151.26
Closing Cash & Cash Equivalent	4.00	3.81	8.32	8.55	46.27
Closing Cash & Cash Equivalent Growth (%)	4.99	-54.21	-2.69	-81.52	-76.58
Total Debt/ CFO (x)	4.02	3.65	9.01	6.41	-4.24

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 98.83 cr for investing activities which is an YoY increase of 168.34%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	-0.59	0.04	-60.75	-1.47	-3.81
Return on Capital Employed (%)	6.48	8.95	-17.42	2.51	-0.65
Return on Assets (%)	-0.31	0.02	-24.13	-0.76	-1.96
Interest Coverage Ratio (x)	2.04	1.87	-0.85	1.74	1.33
Asset Turnover Ratio (x)	0.60	0.56	0.49	0.49	0.46
Price to Earnings (x)	-256.41	5,000.00	-2.36	-53.48	-41.32
Price to Book (x)	1.51	1.89	1.44	0.79	1.57
EV/EBITDA (x)	13.00	13.23	-25.99	13.92	33.75
EBITDA Margin (%)	14.09	16.71	-6.96	10.83	7.88

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	-0.57	-0.09	-60.47	-1.47	-3.83
Return on Capital Employed (%)	6.68	8.83	-17.37	2.51	-0.68
Return on Assets (%)	-0.31	-0.04	-24.15	-0.76	-1.98
Interest Coverage Ratio (x)	2.04	1.86	-0.85	1.73	1.32
Asset Turnover Ratio (x)	0.61	0.56	0.49	0.49	0.46
Price to Earnings (x)	-263.16	-2,000.00	-2.37	-53.48	-40.98
Price to Book (x)	1.51	1.88	1.43	0.79	1.57
EV/EBITDA (x)	13.00	13.31	-26.00	13.92	34.02
EBITDA Margin (%)	14.06	16.59	-6.95	10.81	7.81

Found Financials useful?

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
40%
Positive Movement
since 1st Jan 2005
on basis
58%
Negative Movement
since 1st Jan 2005
on basis
Exclude
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Solara Active Pharma	-377.52	2.23	-0.59	6.48	-0.31	-2.10	6.81	-0.54	-1.68	0.96	0.53	4.35
Orchid Pharma	210.80	3.33	1.59	2.50	1.07	7.22	5.03	2.61	4.05	2.45	0.28	3.53
IOL Chemicals	27.26	2.09	7.65	11.07	5.32	1.42	9.06	5.93	4.69	1.78	0.07	0.62
SMS Pharma	34.82	4.52	12.97	13.84	7.48	19.11	15.75	9.92	11.15	1.81	0.46	6.16
Gufic BioSci	55.16	5.33	9.65	14.93	4.78	10.83	13.04	6.80	6.40	1.55	0.58	8.57
Add More

Annual Ratios (%)

Choose from Peers

Unichem Labs
Panacea Biotec
Morepen Labs
Indoco Remedies
Hikal Ltd

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 2,02,31,281 42.00 % 0.00
Pledge 63,87,036 31.57 % 5.53
FII 55,83,042 11.59 % -0.39
DII 17,91,827 3.71 % 0.10
MF 5,67,155 1.18 % 0.00
Others 2,05,65,412 42.69 % 0.28
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 42.00 42.00 42.01 42.01
Pledge 31.57 26.04 35.32 38.95
FII 11.59 11.98 13.58 14.25
DII 3.71 3.61 2.66 2.59
Mutual Funds 1.18 1.18 1.18 1.18
Others 42.69 42.41 41.75 41.15

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Aditya Birla SL Flexi Cap Direct-G
Equity: Flexi Cap
4
- 20.82
  Amount Invested (in Cr.)
- 0.08124219%
  % of AUM
- 0.00
  % Change (MoM basis)
Aditya Birla SL Manufacturing Equity Direct-G
Equity: Thematic-Manufacturing
- 6.89
  Amount Invested (in Cr.)
- 0.59478844%
  % of AUM
- -4.95
  % Change (MoM basis)
Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.03
  Amount Invested (in Cr.)
- 0.08100493%
  % of AUM
- -3.69
  % Change (MoM basis)

View all Mutual Fund Schemes

Solara Active Pharma Top Searches

Corporate Actions

Recent
Board Meeting
Audited Results
May 08, 2026
General Meeting
Second & Final call of Rs.112.50/- per equity shares
Mar 24, 2026
General Meeting
Second & Final call of Rs.112.50/- per equity shares
Mar 24, 2026

Announced on	Meeting on
May 08, 2026	May 15, 2026
Audited Results
Mar 19, 2026	Mar 24, 2026
Others
Jan 30, 2026	Feb 06, 2026
Quarterly Results
Oct 29, 2025	Nov 05, 2025
Quarterly Results
Jul 18, 2025	Jul 25, 2025
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
May 06, 2021 Aug 18, 2021 30%
Nov 06, 2020 Nov 19, 2020 40%
May 07, 2020 Jul 28, 2020 20%
May 16, 2019 Aug 06, 2019 50%
Bonus
No Data Available
Splits
No Data Available
Rights
Announced on Ex-Date
Jul 05, 2023 May 15, 2024
Rights ratio: 1 share for every 3 held at a price of Rs 375.0

AGM/EGM Meetings

Announced on	Meeting on
Mar 24, 2026	-
Second & Final call of Rs.112.50/- per equity shares
Mar 24, 2026	-
Second & Final call of Rs.112.50/- per equity shares
Mar 24, 2026	-
Second & Final call of Rs.112.50/- per equity shares
Mar 24, 2026	-
Second & Final call of Rs.112.50/- per equity shares
Mar 24, 2026	-
Second & Final call of Rs.112.50/- per equity shares

About Solara Active Pharma

Solara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 2,759.39 Crore) operating in Pharmaceuticals sector.

Solara Active Pharma Sciences Ltd. key Products/Revenue Segments include Active Pharma Ingredients, Other Operating Revenue and Sale of services for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 391.98 Crore, up 12.32 % from last quarter Total Income of Rs 349.00 Crore and up 40.51 % from last year same quarter Total Income of Rs 278.96 Crore. Company has reported net profit after tax of Rs 9.60 Crore in latest quarter.

The company’s top management includes Mr.R Ramakrishnan, Mr.Sandeep Shashikantha Rao, Mr.Mohan Muthunarayanan, Mr.Arun Kumar Pillai, Mr.Kartheek Chintalapati Raju, Mr.Manish Gupta, Dr.Kausalya Santhanam, Mr.Rajendra Kumar Srivastava, Mr.Rajiv Vijay Nabar, Mr.Sarat Kumar, Mr.S Murali Krishna. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2026, the company has a total of 4.82 Crore shares outstanding.

Solara Active Pharma Share Price Today is Rs. 580.70. On previous day, the Solara Active Pharma Share Price (NSE) closed at Rs. 580.0, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 42.0% of the stake in Solara Active Pharma shares, out of which 31.57% was pledged. On the same date, foreign institutional investors' (FII) holdings of Solara Active Pharma stocks was 11.59% as compared to 11.98% in Dec 2025 with decrease of 0.39%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 3.72% as compared to 3.61% in Dec 2025 with increase of 0.11%. Out of the total DII holdings in Solara Active Pharma shares 1.18% was held by mutual funds. The rest including public held is 42.69%. Solara Active Pharma stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Solara Active Pharma Dividend: Ever since 2017, Solara Active Pharma dividends has been paid out around 4 times. As on 11 Jun, 2026, 03:59 PM IST, The overall dividend yield for Solara Active Pharma stands at 0.0%. The last dividend paid was on November 19, 2020 (Rs. 4.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. -1.54.

Solara Active Pharma Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 391.98 Cr. of sales and 12.32% of quarterly net profit, there have been multiple ups and downs in the Solara Active Pharma stock prices in the past few weeks. For example, Solara Active Pharma stock price on 3rd of June 2026 was around Rs. 538.85. Solara Active Pharma share price now stands at an average of Rs. 580.70. Judging by last week's performance, stock is in up trend.

Solara Active Pharma has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Solara Active Pharma share.

Historical Prices and Performance:
Solara Active Pharma, incorporated in 2017 is a Small Cap company (with a market cap of Rs. 2759.39) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Solara Active Pharma stock was -0.59%, 0.04%, -60.75%, -1.47% and -3.81% respectively.
The Solara Active Pharma share gave a 3 year return of 60.88% as compared to Nifty 50 which gave a return of 25.06%.
Solara Active Pharma announced 40.0% final dividend on November 19, 2020.

Key Metrics:
PE Ratio of Solara Active Pharma is -372.39
Prices/Sales Ratio of Solara Active Pharma is 1.38
Price/Book Ratio of Solara Active Pharma is 2.2

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Solara Active Pharma, major competitors and peers include Orchid Pharma, IOL Chemicals, Gufic BioSci and SMS Pharma. As of Dec 2025, the dividend yield of Solara Active Pharma stands at 0.0% while Orchid Pharma, IOL Chemicals, Gufic BioSci and SMS Pharma stand at 0.0%, 0.77%, 0.03% and 0.1% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at -372.39 and 2.2 respectively.

Leadership of Solara Active Pharma :
S Murali Krishna is Co. Secretary & Compl. Officer
Sarat Kumar is Chief Financial Officer
V Sundara Moorthy is Chief Quality Officer
Hero Velladurai is Chief Scientific Officer
Vishal Mathur is Chief Commercial Officer
R Ramakrishnan is Chairperson & Independent Director
Sandeep Shashikantha Rao is Managing Director & CEO
Mohan Muthunarayanan is Whole Time Director & COO
Manish Gupta is Non Executive Director
Kartheek Chintalapati Raju is Non Executive Director
Arun Kumar Pillai is Non Executive Director
Kausalya Santhanam is Independent Director
Rajiv Vijay Nabar is Independent Director
Rajendra Kumar Srivastava is Independent Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, BSE Next 250 Microcap, BSE NEXT 500

Address

�Cyber One�, Unit No. 902,Plot No. 4 & 6, Sector 30A,Vashi,New Mumbai, Maharashtra - 400703

Contact

investors@solara.co.in

http://www.solara.co.in

Executive Leadership

RR

R Ramakrishnan

Chairperson & Independent Director

SS

Sandeep Shashikantha Rao

Managing Director & CEO

MM

Mohan Muthunarayanan

Whole Time Director & COO

AK

Arun Kumar Pillai

Non Executive Director

Show More

Auditors

Deloitte Haskins & Sells LLP

FAQs about Solara Active Pharma share

1. What's the Solara Active Pharma share price today?
Solara Active Pharma share price is Rs 580.70 as on 11 Jun, 2026, 03:59 PM IST. Solara Active Pharma share price is up by 1.38% based on previous share price of Rs 580. Solara Active Pharma share price trend:
- Last 12 Months: Solara Active Pharma share price moved up 13.20%
- Last 3 Years: Solara Active Pharma Share price moved up by 63.10%
2. What is Solara Active Pharma's 52 week high / low?
Solara Active Pharma share price saw a 52 week high of Rs 734.40 and 52 week low of Rs 422.00.
3. What is the market cap of Solara Active Pharma?
Solara Active Pharma share has a market capitalization of Rs 2,782.28 Cr. Within Pharmaceuticals sector, it's market cap rank is 73.
4. What are the returns for Solara Active Pharma share?
Return Performance of Solara Active Pharma Shares:
- 1 Week: Solara Active Pharma share price moved up by 6.89%
5. What is the PE & PB ratio of Solara Active Pharma?
The PE ratio of Solara Active Pharma stands at -372.39, while the PB ratio is 2.03.

Top Gainers

As on 03:59 PM | 11 Jun 2026

Aegis Logistics

925.90

124.90 (15.60%)

111.45

8.52 (8.28%)

DOMS Industries

2,255.40

136.81 (6.46%)

Blue Jet Healthcare

498.45

28.70 (6.11%)

1,923.80

90.80 (4.96%)

Top Losers

As on 03:59 PM | 11 Jun 2026

Balkrishna Ind.

1,974.00

-109.20 (-5.25%)

1,133.10

-60.31 (-5.06%)

155.70

-7.93 (-4.85%)

166.91

-8.00 (-4.57%)

Adani Transmission

1,466.70

-68.90 (-4.49%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.